What Happened?
Shares of scientific consulting firm Exponent (NASDAQ: EXPO) jumped in the afternoon session after UBS raised its price target on the company's stock to $81 from $76. The financial services firm kept a "Neutral" rating on the stock.
The new price target came after UBS held investor meetings with Exponent's management, who showed a positive view of the business outlook. According to the firm's note, the demand for Exponent's services appeared to be improving. This was especially true for its proactive services in the Consumer Electronics sector, which had been soft. UBS also pointed out that growth in the company's full-time staff should lead to a better revenue path in 2026.
After the initial pop the shares cooled down to $74.21, up 0.8% from previous close.
Is now the time to buy Exponent? Access our full analysis report here.
What Is The Market Telling Us
Exponent’s shares are not very volatile and have only had 2 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
The previous big move we wrote about was 24 days ago when the stock gained 3% on the news that comments from a key Federal Reserve official hinted at a potential interest rate cut in December.
John Williams, president of the Federal Reserve Bank of New York, signaled he was open to lowering the fed funds rate—the key interest rate that banks charge each other for overnight loans—to support the job market. Speaking at an event, Williams stated that he sees “room for a further adjustment” for interest rates, which immediately shifted market expectations. Following his remarks, the perceived likelihood of an interest rate cut at the Federal Reserve's December meeting flipped from unlikely to more likely than not. The prospect of lower borrowing costs sent a wave of optimism through the markets, leading to a rally in major indices like the S&P 500, Dow Jones Industrial Average, and the Nasdaq Composite.
Exponent is down 15.6% since the beginning of the year, and at $74.21 per share, it is trading 21% below its 52-week high of $93.95 from January 2025. Investors who bought $1,000 worth of Exponent’s shares 5 years ago would now be looking at an investment worth $844.87.
Microsoft, Alphabet, Coca-Cola, Monster Beverage—all began as under-the-radar growth stories riding a massive trend. We’ve identified the next one: a profitable AI semiconductor play Wall Street is still overlooking.Go here for access to our full report.
